Company Overview

• Cerapedics is enhancing the science of bone repair with its small peptide attachment factor technology platform, i-FACTOR™ bone graft.
• i-FACTOR™ bone graft is the only bone graft substitute that uses a unique anorganic bone mineral (ABM) and small peptide, P-15™, that acts as an attachment factor for specific integrins in osteogenic cells. This novel mechanism of action enhances the natural bone healing process in orthopedic applications resulting in safe, predictable bone formation at a fraction of the cost of conventional growth factors.
• ABM/P-15 was PMA approved for dental applications in 1999 and found to be superior to both DBM and synthetic alloplast material in two prospective clinical studies.
• The ABM/P-15 technology platform is branded i-FACTOR Peptide Enhanced Bone Graft to capture the unique “integrin” and “attachment factor” mechanism of action.
• i-FACTOR Peptide Enhanced Bone Graft received the CE Mark for use in spine, orthopedic and trauma applications in August, 2008 and is available for sale outside the USA.